1. Rule 1: The presence of a carbonyl group (-C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule is also a significant indicator of its potential to cause adverse effects.
Explanation:
1. The presence of a carbonyl group (-C=O) in a molecule is a significant indicator of its potential to cause adverse effects. This is because the carbonyl group is highly reactive and can form covalent bonds with other molecules, which can lead to the formation of toxic metabolites.
2. The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects. This is because the nitro group can react with other molecules to form free radicals, which can cause oxidative stress and damage to cells.
3. The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule is also a significant indicator of its potential to cause adverse effects. This is because halogen atoms can react with other molecules to form free radicals, which can cause oxidative stress and damage to cells.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules are based on the analysis of the given data and the observation that molecules with these properties are more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders. However, it is important to note that these rules are not always accurate and should be used with caution.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, with label 1, contains a nitro group (-NO2). This suggests that the molecule may have adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The second molecule, with label 1, contains a chlorine atom (-Cl). This suggests that the molecule may have adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The third molecule, with label 1, contains a carbonyl group (-C=O). This suggests that the molecule may have adverse effects related to respiratory, thoracic and mediastinal disorders.
However, it is important to note that these rules are based on the given data and may not be applicable to all molecules. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to skin and eye irritation.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for specific functional groups or atoms that are known to be associated with adverse effects.

================================

1. Rule 1: If a molecule contains a functional group such as an aromatic ring or a nitro group, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a functional group such as a carbonyl group, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a functional group such as a hydroxyl group, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a benzene ring, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains both a carbonyl group and a benzene ring, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "CCCCCCCCCCCCCCCCCC(=O)O.CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O" contains a carbonyl group (C=O). This suggests that the molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The molecule with the smiles string "C(CC(=O)O)CO" contains a benzene ring. This suggests that the molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The molecule with the smiles string "CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)OC" contains both a carbonyl group (C=O) and a benzene ring. This suggests that the molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule is a significant indicator of its potential to cause adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a halogen atom (F, Cl, Br, I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a benzene ring, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
Explanation:
- Rule 1: The molecule contains a benzene ring, which is a common structure in many chemicals that are known to cause adverse effects related to respiratory, thoracic, and mediastinal disorders. For example, benzene is a known carcinogen that can cause leukemia and other cancers.
- Rule 2: The molecule contains a chlorine atom, which is a halogen element that is commonly found in many chemicals that are known to cause adverse effects related to respiratory, thoracic, and mediastinal disorders. For example, chlorofluorocarbons (CFCs) are commonly used as refrigerants and solvents, and they have been linked to lung cancer and other respiratory diseases.
- Rule 3: The molecule contains a nitro group, which is a functional group that is commonly found in many chemicals that are known to cause adverse effects related to respiratory, thoracic, and mediastinal disorders. For example, nitrobenzene is a chemical that is used in the production of dyes and explosives, and it has been linked to lung cancer and other respiratory diseases.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
Explanation:
- Rule 1: The presence of a carbonyl group (C=O) in a molecule is often associated with adverse effects related to respiratory, thoracic and mediastinal disorders. This is because the carbonyl group can react with other molecules in the body, leading to the formation of toxic metabolites.
- Rule 2: The presence of a chlorine atom in a molecule is often associated with adverse effects related to respiratory, thoracic and mediastinal disorders. Chlorine atoms can react with other molecules in the body, leading to the formation of toxic metabolites.
- Rule 3: The presence of a nitro group (-NO2) in a molecule is often associated with adverse effects related to respiratory, thoracic and mediastinal disorders. Nitro groups can react with other molecules in the body, leading to the formation of toxic metabolites.

================================

1. Rule 1: If a molecule contains a functional group such as an amidine or guanidine group, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a functional group such as a carbonyl group, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a benzene ring, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a benzene ring, it is more likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group, it is more likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is more likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
These rules can be inferred by analyzing the structures of the molecules and looking for specific functional groups or atoms that are commonly associated with adverse effects. However, it is important to note that these rules are based on the provided data and may not be applicable to all molecules. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If a molecule contains a functional group such as an amidine or guanidine group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a functional group such as a carbonyl group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom, such as fluorine or chlorine, in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a halogen atom, such as fluorine or chlorine, in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a ferrocene group (-Fe(C5H5)2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H6), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-], contains a nitro group (-NO2). The second molecule, O[Fe]=O.O[Fe]=O.[Fe], also contains a nitro group (-NO2). The third molecule, CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3, contains a nitro group (-NO2). The fourth molecule, CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6, contains a nitro group (-NO2). The fifth molecule, C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O, contains a nitro group (-NO2). The sixth molecule, CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3, contains a nitro group (-NO2). The seventh molecule, CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5, contains a nitro

================================

1. Rule 1: If the molecule contains any functional groups such as aldehydes, ketones, amides, or carboxylic acids, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains any halogen atoms such as fluorine, chlorine, bromine, or iodine, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains any aromatic rings, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a sulfur atom (S), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the data as follows:
1. Rule 1: The first molecule, C(=N)(N)N, contains a nitro group (-NO2). It is labeled as 1, which means it is related to the side-effect activity of a molecule related to respiratory, thoracic and mediastinal disorders. Therefore, this molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The second molecule, CCCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O, contains a sulfur atom (S). It is labeled as 1, which means it is related to the side-effect activity of a molecule related to respiratory, thoracic and mediastinal disorders. Therefore, this molecule is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The third molecule, C=CC1=CC=CC=C1S(=O)(=O)O, contains a chlorine atom (Cl). It is labeled as 0, which means it is not related to the side-effect activity of a molecule related to respiratory, thoracic and mediastinal disorders. Therefore, this molecule is not likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (C1=CC=C(C=C1)CCNN 1) contains a nitro group (-NO2), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The second molecule (C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4 1) contains a carbonyl group (-C=O), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The third molecule (CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C 1) contains a halogen atom (-Cl), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.
The fourth molecule (C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)[O-].[Na+] 0) does not contain any of these groups, so it is less likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The fifth molecule (CC(=O)O[C@H]1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N 1) contains a carbonyl group (-C=O), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.
The sixth molecule (CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC 0) does not contain any of these groups, so it is less likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The seventh molecule (C(CN)CNCCSP(=O)(O)O 1) contains a halogen atom (-Cl), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.
The eighth molecule (C1=CC(=C(C=C1N)O)C(=O)O 0) does not contain any of these groups, so it is less likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The ninth molecule (C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C 1) contains a carbonyl group (-C=O), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.
The tenth molecule (C1=COC(=C1)CNC2=NC=NC3=C2NC=N3 0) does not contain any of these groups, so it is less likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The eleventh molecule (CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4 1) contains a halogen atom (-Cl), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.
The twelfth molecule (CC(C)OC(=O)CCC/C=C/CC1C(CC(C1/C=C/C(COC2=CC=CC=C2)(F)F)O)O 1) contains a carbonyl group (-C=O), which suggests that it may have adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a chiral center, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, bromine, or iodine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a bromine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
4. Rule 4: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
5. Rule 5: If a molecule contains a hydroxyl group (-OH), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
6. Rule 6: If a molecule contains a nitrogen atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
7. Rule 7: If a molecule contains a sulfur atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
8. Rule 8: If a molecule contains a phosphorus atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
9. Rule 9: If a molecule contains a carbon atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
10. Rule 10: If a molecule contains a hydrogen atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine or chlorine), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules are based on the observation that the molecules with these functional groups are often associated with respiratory, thoracic and mediastinal disorders. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the adverse effects of a molecule.

================================

1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a chlorine atom in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a chlorine atom in a molecule increases the likelihood of causing adverse effects. Chlorine atoms can react with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group in a molecule increases the likelihood of causing adverse effects. Carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1 1) contains a nitro group (-NO2), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The second molecule (C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl 1) contains a chlorine atom (-Cl), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The third molecule (C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2 0) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The fourth molecule (CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCO 1) contains a carbonyl group (-C=O), which is also known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The fifth molecule (CCCCCN=C(N)NN/C=C/1\C=NC2=C1C=C(C=C2)CO 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The sixth molecule (C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The seventh molecule (C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N.C(C(CO)(CO)N)O 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The eighth molecule (CN(C)C(=N)N=C(N)N 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The ninth molecule (Cl[Zn]Cl 0) does not contain any functional groups that are known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The tenth molecule (COC1=CC=CC=C1OCC(CO)O 0) does not contain any functional groups that are known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The eleventh molecule (CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The twelfth molecule (CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The thirteenth molecule (CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The fourteenth molecule (COC1=CC=CC=C1OCC(CO)O 0) does not contain any functional groups that are known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The fifteenth molecule (CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F 1) contains a carbonyl group (-C=O), which is known to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
The sixteenth molecule (CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a nitrogen atom, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, with label 1, contains a carbonyl group (C=O), which is known to be associated with respiratory, thoracic and mediastinal disorders. The second molecule, with label 0, does not contain a carbonyl group, but it does contain a chlorine atom, which is also associated with respiratory, thoracic and mediastinal disorders. Therefore, the presence of a carbonyl group and/or a chlorine atom in a molecule increases the likelihood of causing adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The third molecule, with label 1, contains a nitrogen atom, which is also associated with respiratory, thoracic and mediastinal disorders. The fourth molecule, with label 0, does not contain a nitrogen atom, but it does contain a chlorine atom, which is associated with respiratory, thoracic and mediastinal disorders. Therefore, the presence of a nitrogen atom and/or a chlorine atom in a molecule increases the likelihood of causing adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The fifth molecule, with label 1, contains a nitrogen atom, which is also associated with respiratory, thoracic and mediastinal disorders. The sixth molecule, with label 0, does not contain a nitrogen atom, but it does contain a chlorine atom, which is associated with respiratory, thoracic and mediastinal disorders. Therefore, the presence of a nitrogen atom and/or a chlorine atom in a molecule increases the likelihood of causing adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a chlorine atom in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a chlorine atom in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a chlorine atom in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a chlorine atom in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can interact with biological molecules such as proteins and enzymes, which can lead to

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C 0) contains a nitro group (-NO2), which is associated with respiratory, thoracic and mediastinal disorders. The second molecule (C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)NS(=O)(=O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O 1) also contains a nitro group (-NO2), which is associated with respiratory, thoracic and mediastinal disorders. The third molecule (CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C 1) contains a nitro group (-NO2), which is associated with respiratory, thoracic and mediastinal disorders.
2. Rule 2: The first molecule (C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)NS(=O)(=O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O 

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If a molecule contains a chiral center, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule (C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O) contains a nitro group (-NO2), which is associated with respiratory, thoracic, and mediastinal disorders.
2. Rule 2: The second molecule (CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC) contains a carbonyl group (-C=O), which is associated with respiratory, thoracic, and mediastinal disorders.
3. Rule 3: The third molecule (C1N2CN3CN1CN(C2)C3 0) contains a halogen atom (-F), which is associated with respiratory, thoracic, and mediastinal disorders.
The fourth molecule (C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O) contains a nitro group (-NO2), which is associated with respiratory, thoracic, and mediastinal disorders.
The fifth molecule (CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O) contains a carbonyl group (-C=O), which is associated with respiratory, thoracic, and mediastinal disorders.
The sixth molecule (C=CCN1CCC23C4C(=O)CCC2(C1CC5=C

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with label 1, C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O, contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: The molecule with label 0, CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13, contains a chlorine atom (-Cl). Therefore, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: The molecule with label 1, C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N, contains a carbonyl group (-C=O). Therefore, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can react with other molecules to form adducts, which can cause damage to cells and tissues.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom (F, Cl, Br, or I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
4. Rule 4: If the molecule contains a sulfur atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
5. Rule 5: If the molecule contains a nitrogen atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
6. Rule 6: If the molecule contains a phosphorus atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
7. Rule 7: If the molecule contains a fluorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
8. Rule 8: If the molecule contains a bromine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
9. Rule 9: If the molecule contains a manganese atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
10. Rule 10: If the molecule contains a selenium atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a benzene ring, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a carbonyl group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a halogen atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
4. Rule 4: If the molecule contains a nitrogen atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
5. Rule 5: If the molecule contains a sulfur atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
6. Rule 6: If the molecule contains a phosphorus atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
7. Rule 7: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
8. Rule 8: If the molecule contains a bromine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
9. Rule 9: If the molecule contains a fluorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
10. Rule 10: If the molecule contains a hydroxyl group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
11. Rule 11: If the molecule contains a methoxy group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
12. Rule 12: If the molecule contains a nitro group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
13. Rule 13: If the molecule contains a cyano group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
14. Rule 14: If the molecule contains a carbonyl group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
15. Rule 15: If the molecule contains a sulfoxide group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
16. Rule 16: If the molecule contains a sulfone group, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
17. Rule 17: If the molecule

================================

1. Rule 1: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If a molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
These rules are based on the data provided and can be used to predict whether a molecule is likely to cause adverse effects based on its structure. However, it is important to note that these rules are not foolproof and should be used with caution. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
2. Rule 2: If the molecule contains a benzene ring, it is less likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory, thoracic, and mediastinal disorders.

================================

